Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|March 1, 1991
Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study GroupP G Koenders, L V Beex, R Langens, et al.
British Journal of Cancer|February 1, 1992
Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissueP G Koenders, W H Peters, T Wobbes, et al.
Calcified Tissue International|December 1, 1994
Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: A 2-year prospective studyH J van Hoof, M J van der Mooren, L M Swinkels, et al.
Clinical Endocrinology|July 1, 1987
The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegalyA E Smals, G F Pieters, A G Smals, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1980
Tamoxifen suppresses gonadotropin-induced 17 alpha-hydroxyprogesterone accumulation in normal menA G Smals, G F Pieters, J I Drayer, et al.
Cancer Research|September 1, 1991
Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancersP G Koenders, L V Beex, A Geurts-Moespot, et al.
Clinical Endocrinology|December 1, 1984
Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administrationG F Pieters, A E Smals, A R Hermus, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 1996
Thyroid function studies in normal pregnant Tanzanian womenE A Kabyemela, L M Swinkels, M M Chuwa, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1983
Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's diseaseG F Pieters, A R Hermus, A G Smals, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumourL V Beex, M A Mackenzie, J M Raemaekers, et al.
Pageof 13